title: Promoting effect of Antrodia camphorata as an immunomodulating adjuvant on the antitumor efficacy of HER-2/neu DNA vaccine.
abstract: It is well known that DNA vaccines induce protective humoral and cell-mediated immune responses in several animal models. Antrodia camphorata (AC) is a unique basidiomycete fungus of the Polyporaceae family that only grows on the aromatic tree Cinnamomum kanehirai Hayata (Lauraceae) endemic to Taiwan. Importantly, AC has been shown to be highly beneficial in the treatment and prevention of cancer. The goal of this study was to investigate whether AC is able to augment the antitumor immune properties of a HER-2/neu DNA vaccine in a mouse model in which p185neu is overexpressed in MBT-2 tumor cells. Compared with the mice that received the HER-2/neu DNA vaccine alone, co-treatment with AC suppressed tumor growth and extended the survival rate. This increase in the antitumor efficacy was attributed to the enhancement of the Th1-like cellular immune response by the HER-2/neu DNA vaccine-AC combination. Evidence for this came from the marked increase in the IFN-gamma mRNA expression in CD4+ T cells in the draining inguinal lymph nodes, an increase in the number of functional HER-2/neu-specific CTLs, and the increased tumor infiltration of both CD4+ and CD8+ T cells, depletion of which abolishes the antitumor effect of the HER-2/neu DNA vaccine-AC therapy. Our results further indicate that the treatment of mice with AC enhanced DC activation and production of Th1-activating cytokines (e.g. IL-12, and IFN-alpha) in the draining lymph nodes, which were sufficient to directly stimulate T cell proliferation and higher IFN-gamma production in response to ErbB2. Overall, these results clearly demonstrate that AC represents a promising immunomodulatory adjuvant that could enhance the therapeutic potency of HER-2/neu DNA vaccines in cancer therapy.
authors.affiliation: Institute of Biomedical Engineering, National Cheng Kung University, Tainan, Taiwan, ROC.
authors.forename: Chia-Hsin
authors.initials: CH
authors.lastname: Huang
authors.forename: Chia-Che
authors.initials: CC
authors.lastname: Chang
authors.forename: Chiu-Mei
authors.initials: CM
authors.lastname: Lin
authors.forename: Sin-Ting
authors.initials: ST
authors.lastname: Wang
authors.forename: Min-Tze
authors.initials: MT
authors.lastname: Wu
authors.forename: Eric I C
authors.initials: EI
authors.lastname: Li
authors.forename: Hsien-Chang
authors.initials: HC
authors.lastname: Chang
authors.forename: Chi-Chen
authors.initials: CC
authors.lastname: Lin
mesh_terms: D000276:Adjuvants, Immunologic / Q000008:administration & dosage*; D000818:Animals; D055491:Antrodia; D017209:Apoptosis / Q000187:drug effects; D002277:Carcinoma / Q000188:drug therapy / Q000276:immunology* / Q000473:pathology; D002457:Cell Extracts / Q000008:administration & dosage / Q000276:immunology; D045744:Cell Line, Tumor; D003602:Cytotoxicity, Immunologic / Q000187:drug effects; D005260:Female; D007371:Interferon-gamma / Q000378:metabolism; D016246:Lymphocytes, Tumor-Infiltrating / Q000187:drug effects / Q000276:immunology / Q000378:metabolism* / Q000473:pathology; D051379:Mice; D008809:Mice, Inbred C3H; D009368:Neoplasm Transplantation; D018719:Erb-b2 Receptor Tyrosine Kinases / Q000235:genetics / Q000276:immunology*; D018417:Th1 Cells / Q000276:immunology; D001749:Urinary Bladder Neoplasms / Q000188:drug therapy / Q000276:immunology* / Q000473:pathology; D019444:Vaccines, DNA
chemical_list: D000276:Adjuvants, Immunologic; D002457:Cell Extracts; D007371:Interferon-gamma; D018719:Erb-b2 Receptor Tyrosine Kinases; D019444:Vaccines, DNA; C524056:Erbb2 protein, mouse
references.citation: Int Heart J. 2009 Mar;50(2):207-20
references.pmid: 19367031
references.citation: Planta Med. 2004 Apr;70(4):310-4
references.pmid: 15095145
references.citation: Life Sci. 2003 Oct 10;73(21):2769-83
references.pmid: 13679244
references.citation: Mol Ther. 2007 Feb;15(2):404-10
references.pmid: 17235320
references.citation: Mol Ther. 2004 Aug;10(2):290-301
references.pmid: 15294176
references.citation: Science. 1989 May 12;244(4905):707-12
references.pmid: 2470152
references.citation: Cancer Res. 2005 Apr 15;65(8):3437-46
references.pmid: 15833879
references.citation: FEMS Microbiol Lett. 2002 Mar 19;209(1):63-7
references.pmid: 12007655
references.citation: Semin Immunol. 1997 Oct;9(5):271-83
references.pmid: 9327522
references.citation: Toxicol Appl Pharmacol. 2008 Mar 1;227(2):291-8
references.pmid: 18078970
references.citation: Cancer Res. 2000 Feb 15;60(4):1035-42
references.pmid: 10706121
references.citation: Cancer Immunol Immunother. 2009 May;58(5):737-48
references.pmid: 18815785
references.citation: Hum Gene Ther. 1996 Nov 10;7(17):2185-94
references.pmid: 8934232
references.citation: Food Chem Toxicol. 2007 Jul;45(7):1249-57
references.pmid: 17316946
references.citation: Hum Gene Ther. 2007 Nov;18(11):1129-39
references.pmid: 17939748
references.citation: J Ethnopharmacol. 2008 Nov 20;120(2):196-203
references.pmid: 18778764
references.citation: J Exp Med. 2002 Aug 19;196(4):541-9
references.pmid: 12186845
references.citation: Clin Cancer Res. 2008 May 15;14(10):3185-92
references.pmid: 18483387
references.citation: J Nat Prod. 2004 Jan;67(1):46-8
references.pmid: 14738384
references.citation: J Virol. 1996 Dec;70(12):9074-8
references.pmid: 8971047
references.citation: Toxicol Appl Pharmacol. 2004 Dec 1;201(2):186-93
references.pmid: 15541758
references.citation: Expert Opin Biol Ther. 2004 Jun;4(6):889-900
references.pmid: 15174971
references.citation: Cancer. 2001 Oct 1;92(7):1896-904
references.pmid: 11745263
references.citation: Cancer Treat Res. 2005;123:137-56
references.pmid: 16211869
references.citation: J Agric Food Chem. 2003 May 21;51(11):3302-8
references.pmid: 12744658
references.citation: Clin Cancer Res. 2007 Oct 15;13(20):6195-203
references.pmid: 17947487
references.citation: J Gene Med. 2008 Jun;10(6):679-89
references.pmid: 18324638
references.citation: Nutr Cancer. 2007;57(1):111-21
references.pmid: 17516868
references.citation: Clin Cancer Res. 2005 Mar 1;11(5):1941-52
references.pmid: 15756020
references.citation: Genet Vaccines Ther. 2009 Jan 30;7:2
references.pmid: 19178753
references.citation: Vaccine. 2007 Jan 8;25(4):719-28
references.pmid: 16962215
references.citation: J Immunol. 2003 Mar 15;170(6):3162-70
references.pmid: 12626574
references.citation: Life Sci. 2002 Jun 14;71(4):469-82
references.pmid: 12044846
references.citation: Proteomics. 2006 Feb;6(3):826-35
references.pmid: 16411266
references.citation: Nat Med. 1996 Oct;2(10):1122-8
references.pmid: 8837611
references.citation: Adv Immunol. 2006;90:175-213
references.pmid: 16730264
references.citation: Semin Cancer Biol. 2002 Feb;12(1):33-42
references.pmid: 11926410
references.citation: J Agric Food Chem. 2002 May 22;50(11):3322-7
references.pmid: 12010005
references.citation: J Agric Food Chem. 2005 Jul 13;53(14):5559-64
references.pmid: 15998114
references.citation: Biosci Biotechnol Biochem. 2007 Jan;71(1):23-30
references.pmid: 17213674
references.citation: J Ethnopharmacol. 2007 Jan 3;109(1):93-103
references.pmid: 16930895
references.citation: Arch Toxicol. 2009 Feb;83(2):121-9
references.pmid: 18709356
references.citation: Nature. 1986 Jan 16-22;319(6050):226-30
references.pmid: 3945311
references.citation: Mol Ther. 2008 Dec;16(12):2011-21
references.pmid: 18813280
references.citation: Anticancer Res. 1998 May-Jun;18(3A):1585-9
references.pmid: 9673374
references.citation: Cancer Res. 1995 Jun 1;55(11):2422-30
references.pmid: 7757996
references.citation: Cancer Res. 2004 Apr 15;64(8):2858-64
references.pmid: 15087404